SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012586
Filing Date
2024-04-19
Accepted
2024-04-19 17:21:54
Documents
16
Period of Report
2024-04-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240419_8k.htm   iXBRL 8-K 33252
2 EXHIBIT 99.1 ex_657264.htm EX-99.1 10588
7 nb01.jpg GRAPHIC 8800
  Complete submission text file 0001437749-24-012586.txt   193103

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nby-20240418.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240418_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240418_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240418_pre.xml EX-101.PRE 11581
19 EXTRACTED XBRL INSTANCE DOCUMENT nby20240419_8k_htm.xml XML 2850
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 24858964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)